Text Size

Androgens for Poor Responders in In Vitro Fertilization

This study has been completed.
Sponsor:
Information provided by:
Hospital Clinic of Barcelona
ClinicalTrials.gov Identifier:
NCT00693108
First received: June 4, 2008
Last updated: June 5, 2008
Last verified: June 2008
History of Changes
  Purpose

it has been shown that androgens in non human primates may favour follicular growth in the ovaries when animals are treated with gonadotropins which are the hormones used in patients receiving treatment with in vitro fertilization. Therefore, this study investigates the potential usefulness of testosterone treatment preceding gonadotropin administration in in vitro fertilization patients having a previous poor response to gonadotropins alone.


Condition Intervention Phase
Ovarian Response
 Drug: Transdermal testosterone
 Phase 3

Study Type: Interventional
Official Title: Transdermal Testosterone to Improve Ovarian Response to Gonadotropins in Poor Responder IVF Patients With Normal Basal Concentrations of FSH

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Hospital Clinic of Barcelona:

Study Start Date: September 2006
Arms Assigned Interventions
Experimental: 1
Transdermal testosterone treatment during the five days preceding gonadotropin therapy in IVF cycles
 Drug: Transdermal testosterone
No Intervention: 2

  Eligibility

Ages Eligible for Study:   19 Years to 39 Years
Genders Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patients receiving the second IVF treatment attempt having the first treatment cycle cancelled because of poor ovarian response to gonadotropins

Exclusion Criteria:

  • Previous ovarian surgery
  • Clinical or laboratory profile suggesting premature ovarian failure
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00693108

Locations
Spain
Hospital Clinic
Barcelona, Spain, 08036
Sponsors and Collaborators
Hospital Clinic of Barcelona
  More Information

Publications:

ClinicalTrials.gov Identifier: NCT00693108     History of Changes
Other Study ID Numbers: IVFANDROGENS
Study First Received: June 4, 2008
Last Updated: June 5, 2008
Health Authority: Spain: Comité Ético de Investigación Clínica

Keywords provided by Hospital Clinic of Barcelona:
Poor
Response
Ovarian
 Stimulation
IVF
Patients

Additional relevant MeSH terms:
Testosterone
Testosterone enanthate
Testosterone undecanoate
Testosterone 17 beta-cypionate
Methyltestosterone
Androgens
Hormones
 Hormones, Hormone Substitutes, and Hormone Antagonists
Physiological Effects of Drugs
Pharmacologic Actions
Antineoplastic Agents, Hormonal
Antineoplastic Agents
Therapeutic Uses
Anabolic Agents

ClinicalTrials.gov processed this record on May 19, 2013